- Home
- NRSN vs OSTX Comparison
NRSN vs OSTX Comparison
Compare NRSN & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- OSTX
- Stock Information
- Founded
- NRSN 2017
- OSTX 2018
- Country
- NRSN Israel
- OSTX United States
- Employees
- NRSN N/A
- OSTX N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- OSTX
- Sector
- NRSN Health Care
- OSTX
- Exchange
- NRSN Nasdaq
- OSTX NYSE
- Market Cap
- NRSN 45.3M
- OSTX 43.0M
- IPO Year
- NRSN 2021
- OSTX 2024
- Fundamental
- Price
- NRSN $1.91
- OSTX $1.83
- Analyst Decision
- NRSN Buy
- OSTX Strong Buy
- Analyst Count
- NRSN 2
- OSTX 3
- Target Price
- NRSN $14.00
- OSTX $18.00
- AVG Volume (30 Days)
- NRSN 427.0K
- OSTX 756.1K
- Earning Date
- NRSN 07-15-2025
- OSTX 08-14-2025
- Dividend Yield
- NRSN N/A
- OSTX N/A
- EPS Growth
- NRSN N/A
- OSTX N/A
- EPS
- NRSN N/A
- OSTX N/A
- Revenue
- NRSN N/A
- OSTX N/A
- Revenue This Year
- NRSN N/A
- OSTX N/A
- Revenue Next Year
- NRSN N/A
- OSTX N/A
- P/E Ratio
- NRSN N/A
- OSTX N/A
- Revenue Growth
- NRSN N/A
- OSTX N/A
- 52 Week Low
- NRSN $0.51
- OSTX $1.12
- 52 Week High
- NRSN $2.60
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- NRSN 48.94
- OSTX N/A
- Support Level
- NRSN $1.81
- OSTX N/A
- Resistance Level
- NRSN $1.96
- OSTX N/A
- Average True Range (ATR)
- NRSN 0.20
- OSTX 0.00
- MACD
- NRSN -0.08
- OSTX 0.00
- Stochastic Oscillator
- NRSN 19.10
- OSTX 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.